Novel cyclic benzimidazole derivatives useful anti-diabetic agents

Details for Australian Patent Application No. 2009309007 (hide)

Owner Metabasis Therapeutics, Inc. Merck Sharp & Dohme Corp.

Inventors Dang, Qun; Chung, De Michael; Gibson, Tony S.; Jiang, Hongjian; Cashion, Daniel K.; Bao, Jianming; Lan, Ping; Lu, Huagang; Makara, Gergely M.; Romero, F. Anthony; Sebhat, Iyassu; Wodka, Dariusz

Agent Spruson & Ferguson

Pub. Number AU-A-2009309007

PCT Pub. Number WO2010/051176

Priority 61/197,606 29.10.08 US

Filing date 19 October 2009

Wipo publication date 6 May 2010

International Classifications

A01N 43/52 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/051176 Priority application(s): WO2010/051176

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Metabasis Therapeutics, Inc.; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009309008-Triazole beta carboline derivatives as antidiabetic compounds

2009309004-Inverted organic photosensitive devices